MRK
Merck & Co., Inc.
NYQ
$119.05
-1.71
(-1.42%)
Neutral · +0.41σ
Grade C
Quarterly financials
last 6 quarters| Quarter | Revenue | Gross profit | Op income | Net income | Free cash flow | Gross % | Op % | Net % |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | $16.29B | $12.09B | $-3.20B | $-4.24B | $2.93B | 74.2% | -19.7% | -26.0% |
| 2025-12-31 | $16.40B | $10.85B | $4.07B | $2.96B | $1.82B | 66.2% | 24.8% | 18.1% |
| 2025-09-30 | $17.28B | $13.42B | $6.55B | $5.79B | $6.83B | 77.7% | 37.9% | 33.5% |
| 2025-06-30 | $15.81B | $12.25B | $5.55B | $4.43B | $2.53B | 77.5% | 35.1% | 28.0% |
| 2025-03-31 | $15.53B | $12.11B | $5.94B | $5.08B | $1.17B | 78.0% | 38.2% | 32.7% |
| 2024-12-31 | $nan | $nan | $nan | $nan | $nan | nan% | nan% | nan% |